DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Dadu R, Waguespack SG, Sherman SI. et al.
Efficacy and tolerability of different starting doses of sorafenib in patients
with differentiated thyroid cancer.
Oncologist 2014;
19: 477-482
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.